Literature DB >> 20144279

The correlation of hemoglobin A1c to blood glucose.

Ken Sikaris1.   

Abstract

The understanding that hemoglobin A1c (HbA1c) represents the average blood glucose level of patients over the previous 120 days underlies the current management of diabetes. Even in making such a statement, we speak of "average blood glucose" as though "blood glucose" were itself a simple idea. When we consider all the blood glucose forms-arterial versus venous versus capillary, whole blood versus serum versus fluoride-preserved plasma, fasting versus nonfasting-we can start to see that this is not a simple issue. Nevertheless, it seems as though HbA1c correlates to any single glucose measurement. Having more than one measurement and taking those measurements in the preceding month improves the correlation further. In particular, by having glucose measurements that reflect both the relatively lower overnight glucose levels and measurements that reflect the postprandial peaks improves not only our ability to manage diabetes patients, but also our understanding of how HbA1c levels are determined. Modern continuous glucose monitoring (CGM) devices may take thousands of glucose results over a week. Several studies have shown that CGM glucose averages account for the vast proportion of the variation of HbA1c. The ability to relate HbA1c to average glucose may become a popular method for reporting HbA1c, eliminating current concerns regarding differences in HbA1c standardization. Hemoglobin A1c expressed as an average glucose may be more understandable to patients and improve not only their understanding, but also their ability to improve their diabetes management. 2009 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20144279      PMCID: PMC2769865          DOI: 10.1177/193229680900300305

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  61 in total

1.  Accuracy evaluation of a new glucometer with automated hematocrit measurement and correction.

Authors:  Lokinendi V Rao; Felice Jakubiak; James S Sidwell; James W Winkelman; Michael L Snyder
Journal:  Clin Chim Acta       Date:  2005-03-31       Impact factor: 3.786

2.  Glucose: a simple molecule that is not simple to quantify.

Authors:  Raymond Gambino
Journal:  Clin Chem       Date:  2007-12       Impact factor: 8.327

3.  Effectiveness of sodium fluoride as a preservative of glucose in blood.

Authors:  A Y Chan; R Swaminathan; C S Cockram
Journal:  Clin Chem       Date:  1989-02       Impact factor: 8.327

4.  Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

Authors:  E Bonora; F Calcaterra; S Lombardi; N Bonfante; G Formentini; R C Bonadonna; M Muggeo
Journal:  Diabetes Care       Date:  2001-12       Impact factor: 19.112

5.  The clinical information value of the glycosylated hemoglobin assay.

Authors:  D M Nathan; D E Singer; K Hurxthal; J D Goodson
Journal:  N Engl J Med       Date:  1984-02-09       Impact factor: 91.245

6.  Comparison of the accuracy of the HemoCue glucose analyzer with the Yellow Springs Instrument glucose oxidase analyzer, particularly in hypoglycemia.

Authors:  Alexander D M Stork; Hans Kemperman; D Willem Erkelens; Thiemo F Veneman
Journal:  Eur J Endocrinol       Date:  2005-08       Impact factor: 6.664

7.  High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.

Authors:  James M Hempe; Ricardo Gomez; Robert J McCarter; Stuart A Chalew
Journal:  J Diabetes Complications       Date:  2002 Sep-Oct       Impact factor: 2.852

8.  Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).

Authors:  Glen H Murata; Richard M Hoffman; William C Duckworth; Christopher S Wendel; Jayendra H Shah
Journal:  Am J Med Sci       Date:  2004-06       Impact factor: 2.378

Review 9.  The effect of continuous subcutaneous glucose monitoring (CGMS) versus intermittent whole blood finger-stick glucose monitoring (SBGM) on hemoglobin A1c (HBA1c) levels in Type I diabetic patients: a systematic review.

Authors:  V T Chetty; A Almulla; A Odueyungbo; L Thabane
Journal:  Diabetes Res Clin Pract       Date:  2008-04-15       Impact factor: 5.602

10.  Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration.

Authors:  Mark A Virtue; Julie K Furne; Frank Q Nuttall; Michael D Levitt
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112

View more
  9 in total

1.  Correlating eligibility criteria generalizability and adverse events using Big Data for patients and clinical trials.

Authors:  Anando Sen; Patrick B Ryan; Andrew Goldstein; Shreya Chakrabarti; Shuang Wang; Eileen Koski; Chunhua Weng
Journal:  Ann N Y Acad Sci       Date:  2016-09-06       Impact factor: 5.691

2.  Significantly High HbA1c in Diabetic Patient with Hb J: Case Report.

Authors:  Wan Nor Fazila Hafizan Wan Nik; Noorazliyana Shafii; Noor Azlin Azraini Che Soh; Rosnah Bahar
Journal:  Oman Med J       Date:  2022-07-31

3.  Vitamin D, Calcium, Magnesium, and Potassium Consumption and Markers of Glucose Metabolism in the Hispanic Community Health Study/Study of Latinos.

Authors:  Cristina Palacios; Cynthia M Pérez; Lorena González-Sepúlveda; Leonor Corsino; Sandra S Albrecht; Anna Maria Siega-Riz; Ramon A Durazo-Arvizu; Sarah Casagrande; Daniela Sotres-Alvarez; M Larissa Avilés-Santa
Journal:  J Am Nutr Assoc       Date:  2020-11-30

Review 4.  Safe and pragmatic use of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement.

Authors:  Sanjay Kalra; Sujoy Ghosh; A H Aamir; Md Tofail Ahmed; Mohammod Feroz Amin; Sarita Bajaj; Manash P Baruah; Uditha Bulugahapitiya; A K Das; Mimi Giri; Sonali Gunatilake; Saeed A Mahar; Md Faruque Pathan; Nazmul Kabir Qureshi; S Abbas Raza; Rakesh Sahay; Santosh Shakya; Dina Shreshta; Noel Somasundaram; Manilka Sumanatilleke; A G Unnikrishnan; Achini Madushani Wijesinghe
Journal:  Indian J Endocrinol Metab       Date:  2017 Jan-Feb

5.  Prevalence, awareness, treatment and control of diabetes and impaired fasting glucose in the Southern Cone of Latin America.

Authors:  Vilma Irazola; Adolfo Rubinstein; Lydia Bazzano; Matias Calandrelli; Chen Chung-Shiuan; Natalia Elorriaga; Laura Gutierrez; Fernando Lanas; Jose A Manfredi; Nora Mores; Hector Olivera; Rosana Poggio; Jacqueline Ponzo; Pamela Seron; Jiang He
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

6.  Albumin Abundance and Its Glycation Status Determine Hemoglobin Glycation.

Authors:  Mashanipalya G Jagadeeshaprasad; Vinashya Venkatasubramani; Ambika G Unnikrishnan; Mahesh J Kulkarni
Journal:  ACS Omega       Date:  2018-10-10

7.  Effect of Cognitive Behavioral Therapy for Insomnia on Insomnia Symptoms for Individuals With Type 2 Diabetes: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Mohammed M Alshehri; Aqeel M Alenazi; Jeffrey C Hoover; Shaima A Alothman; Milind A Phadnis; Christie A Befort; John M Miles; Jason L Rucker; Patricia M Kluding; Catherine F Siengsukon
Journal:  JMIR Res Protoc       Date:  2019-12-19

8.  Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis.

Authors:  Ezra Belay Ketema; Kelemu Tilahun Kibret
Journal:  Arch Public Health       Date:  2015-09-25

9.  Targeted quantification of N-1-(carboxymethyl) valine and N-1-(carboxyethyl) valine peptides of β-hemoglobin for better diagnostics in diabetes.

Authors:  Mashanipalya G Jagadeeshaprasad; Kedar B Batkulwar; Nishita N Meshram; Shalbha Tiwari; Arvind M Korwar; Ambika G Unnikrishnan; Mahesh J Kulkarni
Journal:  Clin Proteomics       Date:  2016-03-29       Impact factor: 3.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.